GSK3B and familial pancreatic carcinoma: In particular, a recent study by Shimasaki et al. conducted gene profiling analyses on pancreatic cancer cell lines and revealed that GSK3β inhibition altered gene expression changes induced by chemotherapeutic drugs [39].